It’s a long way to the top (if you want to personalize immunotherapy)

Por Haebe, Sarah, Weigert, Oliver
Publicado no J Immunother Cancer (2017)

Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle

Por Rank, Andreas, Weigert, Oliver, Ostermann, Helmut
Publicado em 2010

Impact of age on clinical risk scores in follicular lymphoma

Por Alig, Stefan, Jurinovic, Vindi, Pastore, Alessandro, Haebe, Sarah, Schmidt, Christian, Zoellner, Anna-Katharina, Dreyling, Martin, Unterhalt, Michael, Hoster, Eva, Hiddemann, Wolfgang, Weigert, Oliver
Publicado no Blood Adv (2019)

Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production

Por Ward, Patrick S., Cross, Justin R., Lu, Chao, Weigert, Oliver, Abel-Wahab, Omar, Levine, Ross L., Weinstock, David M., Sharp, Kim A., Thompson, Craig B.
Publicado em 2011

Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2

Por van Bodegom, Diederik, Zhong, Jun, Kopp, Nadja, Dutta, Chaitali, Kim, Min-Sik, Bird, Liat, Weigert, Oliver, Tyner, Jeffrey, Pandey, Akhilesh, Yoda, Akinori, Weinstock, David M.
Publicado em 2012

Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes

Por Shindoh, Nobuaki, Yoda, Akinori, Yoda, Yuka, Sullivan, Timothy J., Weigert, Oliver, Lane, Andrew A., Kopp, Nadja, Bird, Liat, Rodig, Scott J., Fox, Edward A., Weinstock, David M.
Publicado em 2012

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones

Por Melchardt, Thomas, Hufnagl, Clemens, Weinstock, David M., Kopp, Nadja, Neureiter, Daniel, Tränkenschuh, Wolfgang, Hackl, Hubert, Weiss, Lukas, Rinnerthaler, Gabriel, Hartmann, Tanja N., Greil, Richard, Weigert, Oliver, Egle, Alexander
Publicado no Oncotarget (2016)

Convergence of risk prediction models in follicular lymphoma

Por Silva, Anjali, Bassim, Sleiman, Sarkozy, Clémentine, Mottok, Anja, Lackraj, Tracy, Jurinovic, Vindi, Brodtkorb, Marianne, Lingjaerde, Ole Christian, Sehn, Laurie H., Gascoyne, Randy D., Weigert, Oliver, Steidl, Christian, Kridel, Robert
Publicado no Haematologica (2019)

Acetylation of C/EBPα inhibits its granulopoietic function

Por Bararia, Deepak, Kwok, Hui Si, Welner, Robert S., Numata, Akihiko, Sárosi, Menyhárt B., Yang, Henry, Wee, Sheena, Tschuri, Sebastian, Ray, Debleena, Weigert, Oliver, Levantini, Elena, Ebralidze, Alexander K., Gunaratne, Jayantha, Tenen, Daniel G.
Publicado no Nat Commun (2016)

BCL2 suppresses PARP1 function and non-apoptotic cell death

Por Dutta, Chaitali, Day, Tovah, Kopp, Nadja, van Bodegom, Diederik, Davids, Matthew S., Ryan, Jeremy, Bird, Liat, Kommajosyula, Naveen, Weigert, Oliver, Yoda, Akinori, Fung, Hua, Brown, Jennifer R., Shapiro, Geoffrey I., Letai, Anthony, Weinstock, David M.
Publicado em 2012

Impact of age on genetics and treatment efficacy in follicular lymphoma

Por Alig, Stefan, Jurinovic, Vindi, Pastore, Alessandro, Bararia, Deepak, Häbe, Sarah, Hellmuth, Johannes C., Kridel, Robert, Gascoyne, Randy, Schmidt, Christian, Zöllner, Anna-Katharina, Buske, Christian, Dreyling, Martin, Unterhalt, Michael, Hiddemann, Wolfgang, Hoster, Eva, Weigert, Oliver
Publicado no Haematologica (2018)

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016

Por Qu, Xiaoyu, Li, Hongli, Braziel, Rita M., Passerini, Verena, Rimsza, Lisa M., Hsi, Eric D., Leonard, John P., Smith, Sonali M., Kridel, Robert, Press, Oliver, Weigert, Oliver, LeBlanc, Michael, Friedberg, Jonathan W., Fang, Min
Publicado no Blood (2019)

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy

Por Mottok, Anja, Jurinovic, Vindi, Farinha, Pedro, Rosenwald, Andreas, Leich, Ellen, Ott, German, Horn, Heike, Klapper, Wolfram, Boesl, Michael, Hiddemann, Wolfgang, Steidl, Christian, Connors, Joseph M., Sehn, Laurie H., Gascoyne, Randy D., Hoster, Eva, Weigert, Oliver, Kridel, Robert
Publicado no Blood (2018)

Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation

Por Weigert, Oliver, Kopp, Nadja, Lane, Andrew A., Yoda, Akinori, Dahlberg, Suzanne E., Neuberg, Donna, Bahar, Anita Y., Chapuy, Bjoern, Kutok, Jeff L., Longtine, Janina, Kuo, Frank C., Haley, Terry, Salois, Maura, Sullivan, Timothy J., Fisher, David C., Fox, Edward A., Rodig, Scott J., Antin, Joseph H., Weinstock, David M.
Publicado no Cancer Discov (2011)

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

Por Jurinovic, Vindi, Kridel, Robert, Staiger, Annette M., Szczepanowski, Monika, Horn, Heike, Dreyling, Martin H., Rosenwald, Andreas, Ott, German, Klapper, Wolfram, Zelenetz, Andrew D., Barr, Paul M., Friedberg, Jonathan W., Ansell, Stephen, Sehn, Laurie H., Connors, Joseph M., Gascoyne, Randy D., Hiddemann, Wolfgang, Unterhalt, Michael, Weinstock, David M., Weigert, Oliver
Publicado no Blood (2016)

Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells

Por Body, Simon, Esteve-Arenys, Anna, Miloudi, Hadjer, Recasens-Zorzo, Clara, Tchakarska, Guergana, Moros, Alexandra, Bustany, Sophie, Vidal-Crespo, Anna, Rodriguez, Vanina, Lavigne, Régis, Com, Emmanuelle, Casanova, Isolda, Mangues, Ramón, Weigert, Oliver, Sanjuan-Pla, Alejandra, Menéndez, Pablo, Marcq, Bénédicte, Picquenot, Jean-Michel, Pérez-Galán, Patricia, Jardin, Fabrice, Roué, Gaël, Sola, Brigitte
Publicado no Sci Rep (2017)

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

Por Tobin, Joshua W.D., Keane, Colm, Gunawardana, Jay, Mollee, Peter, Birch, Simone, Hoang, Thanh, Lee, Justina, Li, Li, Huang, Li, Murigneux, Valentine, Fink, J. Lynn, Matigian, Nicholas, Vari, Frank, Francis, Santiyagu, Kridel, Robert, Weigert, Oliver, Haebe, Sarah, Jurinovic, Vindi, Klapper, Wolfram, Steidl, Christian, Sehn, Laurie H., Law, Soi-Cheng, Wykes, Michelle N., Gandhi, Maher K.
Publicado no J Clin Oncol (2019)

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Por Odejide, Oreofe, Weigert, Oliver, Lane, Andrew A., Toscano, Dan, Lunning, Matthew A., Kopp, Nadja, Kim, Sunhee, van Bodegom, Diederik, Bolla, Sudha, Schatz, Jonathan H., Teruya-Feldstein, Julie, Hochberg, Ephraim, Louissaint, Abner, Dorfman, David, Stevenson, Kristen, Rodig, Scott J., Piccaluga, Pier Paolo, Jacobsen, Eric, Pileri, Stefano A., Harris, Nancy L., Ferrero, Simone, Inghirami, Giorgio, Horwitz, Steven M., Weinstock, David M.
Publicado no Blood (2014)

Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

Por Alig, Stefan, Jurinovic, Vindi, Shahrokh Esfahani, Mohammad, Haebe, Sarah, Passerini, Verena, Hellmuth, Johannes C., Gaitzsch, Erik, Keay, William, Tahiri, Natyra, Zoellner, Anna, Rosenwald, Andreas, Klapper, Wolfram, Stein, Harald, Feller, Alfred, Ott, German, Staiger, Annette M., Horn, Heike, Hansmann, Martin L., Pott, Christiane, Unterhalt, Michael, Schmidt, Christian, Dreyling, Martin, Alizadeh, Ash A., Hiddemann, Wolfgang, Hoster, Eva, Weigert, Oliver
Publicado no Blood Adv (2020)

Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance

Por Yoda, Akinori, Adelmant, Guillaume, Tamburini, Jerome, Chapuy, Bjoern, Shindoh, Nobuaki, Yoda, Yuka, Weigert, Oliver, Kopp, Nadja, Wu, Shuo-Chieh, Kim, Sunhee S., Liu, Huiyun, Tivey, Trevor, Christie, Amanda L., Elpek, Kutlu G., Card, Joseph, Gritsman, Kira, Gotlib, Jason, Deininger, Michael W., Makishima, Hideki, Turley, Shannon J., Javidi-Sharifi, Nathalie, Maciejewski, Jaroslaw P., Jaiswal, Siddhartha, Ebert, Benjamin L., Rodig, Scott J., Tyner, Jeffrey W., Marto, Jarrod A., Weinstock, David M., Lane, Andrew A.
Publicado no Nat Med (2014)